Skip to main content
Log in

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/remdesivir

Treatment failure and off-label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Loyalka P, et al. Early Usage of Extracorporeal Membrane Oxygenation in the Absence of Invasive Mechanical Ventilation to Treat COVID-19-related Hypoxemic Respiratory Failure. ASAIO Journal 67: 392-394, No. 4, Apr 2021. Available from: URL: http://doi.org/10.1097/MAT.0000000000001393

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antibacterials/convalescent-anti-SARS-CoV-2-plasma/remdesivir. Reactions Weekly 1859, 33 (2021). https://doi.org/10.1007/s40278-021-97129-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-97129-0

Navigation